1. Tomczyk S, Bennett NM, Stoecker C, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥ 65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63:822–5.
2. National Foundation for Infectious Diseases [Internet]. Pneumococcal disease.
http://www.adultvaccination.org/pneumococcal_vaccine_vaccination_adult_immunization.htm
Accessed 5 Jul 2017.
3. Kobayashi M, Bennett NM, Gierke R, et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2015;64(34):944–7.
4. Centers for Disease Control and Prevention (CDC) [Internet]. Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6434a4.htm
Accessed 5 Jun 2019.
5. Centers for Disease Control and Prevention (CDC) [Internet]. ACIP Evidence to Recommendations Framework.
https://www.cdc.gov/vaccines/acip/recs/grade/downloads/ACIP-evidence-rec-frame-508.pdf
Accessed 9 Nov 2018.